By Amber Deter A Ginkgo Bioworks IPO is coming to the market by a special purpose acquisition company (SPAC). Soaring Eagle Acquisition (Nasdaq: SRNG) and Ginkgo announced a merger agreement, and investors want to know when they can expect Ginkgo Bioworks stock.
But is Ginkgo Bioworks a good investment opportunity? Here’s what we know…
Ginkgo Bioworks IPO: The Company
A group of MIT scientists founded Ginkgo Bioworks in 2008. It’s a biotech company based in Boston, Massachusetts. The goal is to build made-to-order microbes for customers to grow better products instead of manufacturing them. The company does this with its cell programming platform. The platform uses …read more
